Milner Institute signs MOU with Yonsei University for joint research in quantum computing
The agreement is expected to serve as a critical foundation for activating international joint research, academic exchange and research collaboration in quantum fields, including quantum computing.
Milner Institute delivers Cambridge-Google AlphaFold Workshop
The workshop brought together leading academic researchers, industry experts and innovators to explore the fundamentals of AlphaFold – an artificial intelligence (AI) program developed by Google DeepMind to predict the 3D structure of proteins.
The role of AI and omnichannel strategies in healthcare marketing
Co-authored by Jose Maria (Chema) Guido Avila, Sanofi
Sphere Bio expands APAC distribution network to strengthen presence in region
Operational scale-up accelerates global growth strategy to increase regional access and technical support
The 8Cs of smart business expansion: A simple framework for going big, the right way
By Gary Jennings, Innovation Director, The EpiCentre.
World-first trial indicates immunosuppression may help treat Parkinson’s
A groundbreaking trial, led from Cambridge, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease, according to results presented this weekend at the world’s most prestigious neurodegeneration conference AD/PD.
ELRIG appoints Dr Del Trezise as Chair
Cambridge, UK, 8 April 2025: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board.
IBL International collaborates with Grifols on advanced biomarker panels
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Case Study - Addenbrooke’s Hospital: Connectivity that bridges gaps
Addenbrooke’s Hospital, part of the Cambridge University Hospitals NHS Trust on the Cambridge Biomedical Campus, is a healthcare titan serving 20,000 staff, patients, and visitors daily. This bustling hub of medical care and research demands communication that matches its scope.
Signal lost? You’re not alone
Ever had an important call drop right when you needed it most? Maybe you were closing a deal, or simply trying to send an urgent email - only to be met with silence.
Schools broadband & Breathe Technology: A powerful partnership for education IT
Breathe Technology is proud to be the authorised support partner for Schools Broadband in Peterborough, together we can give you a smarter, safer, and more streamlined solution.
CMR Surgical secures more than $200M to accelerate growth
CMR Surgical, the global surgical robotics company, announces the successful closing of a financing round of over $200 million through a combination of equity and debt capital to support the company’s ambitious growth plans.
How to leverage business growth in 2025
1. Businesses must develop flexible strategies and financial resilience to tackle geopolitical instability, economic volatility, and evolving regulations.
Future-proof your School’s internet – Free assessment available
Is your school’s internet fast, secure, and fully compliant? Reliable connectivity is no longer a luxury – it’s essential.
Cambridge Cognition selected for two Phase 3 Trials combining digital cognitive and voice solutions
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company to provide digital cognitive and voice assessments for two Phase 3 clinical trials in adolescents with Major Depressive Disorder (MDD). Both contracts are set to commence this year, with the first…
Efficient Subcontracting in Europe: Expanding HMLV Capabilities
In today's dynamic business environment, companies are increasingly turning to subcontracting as a strategic approach to manage high-mix, low-volume (HMLV) production
Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits
Männedorf, Switzerland, April 3, 2025 – Tecan Group (SIX Swiss Exchange: TECN), announces an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity In
BioTrinity 2025: Over 800 professionals convene to paint a picture of hope for UK life sciences
BioTrinity 2025 welcomed over 800 delegates, matching the highest-ever attendance set in 2024.Three action-packed tracks covered investment trends, regulatory shifts, and cutting-edge scientific advancements.Nearly 10,000 meetings requested, with 2,000
Smarter buildings, stronger signals – why connectivity is the backbone of modern business
Why Connectivity Matters More Than Ever
Recognising the signs of abuse
Being an unpaid carer for a family member or friend with a disability or long-term illness can come with hidden challenges that often aren’t talked about.
CMR Surgical raises more than $200m to accelerate growth in US and globally
Global surgical robotics company CMR Surgical in Cambridge has closed a funding round of more than $200 million to underpin worldwide expansion – notably in the US.
The haul has been raised through a combination of equity and debt capital to support the company’s ambitious growth plans.
S&W launches as a leader in the accountancy mid-market
The independent accountancy and advisory business ( formally separate from Evelyn Partners from 31 March 2025) has launched under a new brand – S&W – building on the firm’s heritage but with a clear signal to a new, well invested, client-focused organisation at the forefront of providing the
4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA
Cambridge, UK, 02 April 2025 – 4basebio PLC, a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, announces that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines
Scientists unlock secret behind how smoking and drinking alcohol causes cancer
Scientists have revealed exactly how tobacco smoke damages DNA to drive the development of different types of head and neck cancer, a finding that could unlock new treatments and prevention strategies.
Goodwin Advised Harbour BioMed in $175 Million Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies
The Life Sciences team advised Harbour BioMed on a global strategic collaboration with AstraZeneca to discover and develop next-generation multi-specific antibodies for immunology, oncology, and beyond. The strategic collaboration includes an option to license multiple programs utilizing Harbour BioMed’s proprietary Harbour Mice® fully human antibody technology platform in multiple therapeutic…